For more information, ask your doctor or pharmacist. Please see the RITUXAN full Prescribing Information, including the Medication Guide, for additional. 13 Oct rituximab. PART I: HEALTH PROFESSIONAL INFORMATION. SUMMARY PRODUCT INFORMATION. Route of. Administration. Dosage Form /. Rituxan® SC. rituximab. Product Monograph. RITUXAN SC Product Monograph · Consumer Information. The files in this section are available in

Author: Vudojinn Nimuro
Country: Laos
Language: English (Spanish)
Genre: Environment
Published (Last): 7 January 2018
Pages: 209
PDF File Size: 16.59 Mb
ePub File Size: 13.72 Mb
ISBN: 890-6-84397-944-7
Downloads: 43279
Price: Free* [*Free Regsitration Required]
Uploader: Yojind

Rituxan can cause serious side rituxan prescribing information, including: The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Hepatitis B reactivation may cause serious liver problems rituxan prescribing information liver failure and death. Severe skin and mouth reactions: You may also report side effects infofmation Genentech at Administer aggressive intravenous hydration and anti-hyperuricemic therapy in patients at high risk for TLS.

Rituxan prescribing information within 24 hours of Rituxan infusion have occurred. Before receiving Presrcibing, tell your healthcare provider if you: Rituxan may cause chest pain, and irregular heartbeats, and heart attack.

Tell your healthcare provider right away if you have any stomach-area pain during inforjation with Rituxan What are common side effects during treatment with Rituxan? Rituxan rituxan prescribing information cause serious side effects that can lead to death, including: Renal toxicity has occurred in patients who experience tumor lysis syndrome and in rituxan prescribing information with administered concomitant cisplatin therapy during clinical trials.

Upon further treatment, the proportions of patients with infusion reactions were similar between anti-rituximab antibody positive informatiin negative patients, and most reactions were mild to moderate.

PRODUCT INFORMATION

Closely monitor the following patients: You should not receive Rituxan if you have active hepatitis B liver disease. Abdominal pain, bowel obstruction and perforation, in some cases leading to death, can occur in patients receiving Rituxan in combination with chemotherapy.

Infections may include fever, rituxan prescribing information. Hepatitis B reactivation may cause serious liver problems, including liver failure, and death. Hives red itchy welts or rash Itching Swelling of your lips, tongue, throat, or face Sudden cough Shortness of breath, difficulty infogmation, or wheezing Weakness Dizziness or feel faint Palpitations feel like your heart is racing or fluttering Chest pain.

For RA patients, rituxan prescribing information should follow current immunization guidelines and administer non-live vaccines at least 4 weeks prior to a course of Rituxan.

You should not receive Rituxan if you have active hepatitis B liver disease. Your healthcare provider will monitor you rituxan prescribing information hepatitis B infection during and for several months after you stop receiving Rituxan. You may rituxan prescribing information report side effects to Genentech at Prescribing Information Medication Guide. Your healthcare provider may monitor rktuxan heart during and after treatment with RITUXAN if you have inflrmation of heart problems or have a history of heart problems.

People with weakened immune systems can get PML. Your healthcare provider may do blood tests to check you for TLS. TLS can cause you to have: Advise pregnant women of the risk to a fetus. Your use of third-party websites is at your own peescribing and subject to the terms and conditions of use for such sites.

RITUXAN HYCELA™ (rituximab/hyaluronidase human) for FL, DLBCL and CLL

People with rituxan prescribing information infections should not receive Rituxan Heart Problems: PML can result in death or severe disability. Call your doctor for medical advice about side effects. Genentech is neither affiliated with nor endorses any of the aforementioned organizations.

N Engl J Med. Discontinue infusions for serious or life-threatening cardiac arrhythmias. Click “Proceed” if you rituxan prescribing information a healthcare professional. Limited prescribinng are available on the rituxan prescribing information of the use of biologic agents or DMARDs other than methotrexate in RA patients exhibiting peripheral B-cell depletion following treatment with Rituxan.

Prescribing Information Medication Guide Safety. Tell your healthcare provider right away if you have any new or worsening symptoms or if anyone close to you notices these symptoms: Genentech does not recommend and does not endorse the content on any third-party websites.

The clinical relevance of anti-rituximab antibody formation in Rituxan-treated patients is unclear. Rates of serious infection remain stable in patients receiving subsequent courses. Serious infusion reactions can happen during your infusion or within 24 hours after your rituxan prescribing information of Rituxan prescribing information. TLS is caused by the fast breakdown of cancer cells. Tell your healthcare provider right away if you have any of the following signs or symptoms of TLS: TLS can happen within hours after an infusion of Rituxan.

Premedication with glucocorticoids should also be considered. Tell your healthcare provider right away if you have chest pain or irregular heartbeats during treatment with Rituxan. TLS can rituxan prescribing information you to have kidney failure and the need for dialysis treatment or an abnormal heart rhythm.